News/Traws Pharma Provides Updated Guidance on Influe…
GlobeNewswire🇺🇸 USUnresolved

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Resubmission of updated data package to MHRA, expected in 3Q 2026, to enable Phase 2a human influenza Challenge study to proceed Resubmission of updated data package to MHRA, expected in 3Q 2026, to enable Phase 2a human influenza Challenge study to proceed

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program